Graph learning based suicidal ideation detection via tree-drawing test. [PDF]
Liu Y, Zheng J, Zeng Y, Luo F, Tian X.
europepmc +1 more source
Project Trinidad: explosive excavation tests in sandstone and shale.
B.B. Redpath
openalex +2 more sources
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira+14 more
wiley +1 more source
Exploring unsupervised feature extraction algorithms: tackling high dimensionality in small datasets. [PDF]
Niu H+4 more
europepmc +1 more source
Project Rio Blanco: comparative postdetonation hydrologic testing
C.F. Knutson
openalex +1 more source
Third Report of the Normandy Reservoir Salvage Project: 1973 Testing Program, Lithic Resource Survey, Lithic Annealing Project, and Report on Plant and Faunal Remains from the Banks III Site. C. R. Mc‐Collough and Charles H. Faulkner [PDF]
Carl Kuttruff
openalex +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian+10 more
wiley +1 more source
Geometry-Constrained Learning-Based Visual Servoing with Projective Homography-Derived Error Vector. [PDF]
Zhang Y+5 more
europepmc +1 more source
Solar Photovoltaic Field Tests and Applications Project. Monthly report, 1 October--31 October 1977
Not Given Author
openalex +2 more sources
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga+8 more
wiley +1 more source